Technology News and Research

RSS

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

The U.S. Patent and Trademark Office has issued the University of Utah U.S. patent No. U.S. 6,787,338 (the '338 patent) relating to methods of rapid nucleic acid amplification.

8 Sep 2004

NMT Medical announces favorable patent decision

NMT Medical today announced a favorable decision by the U.S. Patent and Trademark Office Board of Appeals relating to the Company's patent infringement actions against AGA Medical Corp.

8 Sep 2004

Phase I clinical trial of new drug for severe asthma

Cambridge Antibody Technology today announced that it is starting a Phase I clinical trial of CAT-354, a human anti-IL-13 monoclonal antibody, which is a potential treatment for severe asthma, following recent approval from the Medicines and Healthcare products Regulatory Agency (MHRA).

8 Sep 2004

MorphoSys obtains license on human cell line technology for use in its antibody research

MorphoSys has announced today a non-exclusive license agreement with Dutch biotechnology company Crucell and DSM Biologics.

8 Sep 2004

New IBM technology could bring the promise of personalized medicine one step closer

Using a basic computer language, the researchers created a "smart" DNA stream that contains a patient's entire medical record

8 Sep 2004

Enhanced technology with improved features drives the mobile medical imaging equipment market

The increasing demand for digitisation among hospitals and high price of static modalities are driving demand for mobile medical imaging equipment.

8 Sep 2004

Pioneering work with human embryonic stem cells could speed up development of new treatments for Parkinson’s and diabetes

Pioneering work with human embryonic stem (hES) cells could speed up the development of new treatments for a range of degenerative disorders such as Parkinson’s disease and diabetes according to Dr Stephen Minger of King’s College London, speaking today at the BA Festival of Science.

8 Sep 2004

First biological assessment tool for Attention Deficit Hyperactivity Disorder

On the eve of the first National ADHD Awareness Day, the first biological assessment tool for Attention Deficit Hyperactivity Disorder is being introduced in Denver.

7 Sep 2004

Phico Therapeutics secures funding to tackle superbug

Phico Therapeutics Ltd, a Cambridge-based company that has developed a unique anti-bacterial technology to treat the hospital superbug, MRSA, has raised £550,000 with the help of Oxfordshire Investment Opportunity Network, Europe’s leading technology business angel network.

6 Sep 2004

Protein-rich teething rusk to help stop children suffering Kwashiorkor

Two food technology students from RMIT University, Australia, who developed a teething rusk for malnourished children in developing countries have won a national award.

4 Sep 2004

Britons are taller, straighter and larger than ever

Size UK measured the body shapes of around 1,500 Mancunian men and women in October 2001 among 10,000 measured nationwide under the survey backed by the department of trade and industry and a consortium or retailers including Marks & Spencer, GUS, N Brown and Redcats.

2 Sep 2004

Women perceive color better than men

Stereotypes about the superior color sense of women may well be rooted in genetics. Brian Verrelli, a researcher at the Biodesign Institute at ASU, is co-collaborator on a study suggesting that natural genetic selection has provided women with a frequent ability to better discriminate between colors than men.

2 Sep 2004

Chemotherapy experts refute ASCO recommendations on use of drug sensitivity and resistance assays

A group of leading chemotherapy experts assembled as the Clinical Oncologists for Individualized Therapy (COFIT) refute the findings of the American Society of Clinical Oncology (ASCO) technology assessment panel regarding the use of chemotherapy sensitivity and resistance assays (CSRAs).

1 Sep 2004

Launch of one of the US's largest electronic medical record implementations

As part of an ongoing mission to improve the quality and safety of patient care, Buffalo Hospital is the first Allina hospital to transition away from paper processes and begin using an electronic medical record system that will ultimately be shared by all of Allina’s seventy-six sites, including 11 hospitals and sixty-five clinics.

1 Sep 2004

Patent issued for non invasive treatment of kidney and ureteric stone technology

Issued on August 24, 2004, the patent covers the new technology of Twinheads(R) which uses two or more shock wave sources in the extracorporeal shock wave lithotripsy; the non invasive treatment of kidney and ureteric stones. Further patents are pending.

1 Sep 2004

Chiron acquires a variant Creutzfeldt-Jakob disease research company

Chiron Corporation has announced that it had acquired Prion Solutions Inc., a privately held company based in La Jolla, Calif., focused on research into variant Creutzfeldt-Jakob disease (vCJD) and other prion-related diseases. Financial terms of the acquisition were not disclosed.

1 Sep 2004

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

“There are many types and subtypes of lymphoma, some of which are easy to detect, but many that are very difficult to identify,” says Antonio Giordano, M.D., Ph.D., director of the Sbarro Institute at Temple and one of the study’s principal investigators.

1 Sep 2004

Technology News and Research

University of Utah gets patent approval relating to methods of rapid nucleic acid amplification

NMT Medical announces favorable patent decision

Phase I clinical trial of new drug for severe asthma

MorphoSys obtains license on human cell line technology for use in its antibody research

New IBM technology could bring the promise of personalized medicine one step closer

Enhanced technology with improved features drives the mobile medical imaging equipment market

Pioneering work with human embryonic stem cells could speed up development of new treatments for Parkinson’s and diabetes

First biological assessment tool for Attention Deficit Hyperactivity Disorder

Phico Therapeutics secures funding to tackle superbug

Protein-rich teething rusk to help stop children suffering Kwashiorkor

Britons are taller, straighter and larger than ever

Women perceive color better than men

Chemotherapy experts refute ASCO recommendations on use of drug sensitivity and resistance assays

Launch of one of the US's largest electronic medical record implementations

Patent issued for non invasive treatment of kidney and ureteric stone technology

Chiron acquires a variant Creutzfeldt-Jakob disease research company

Researchers accurately pinpoint the types of lymphoma, Hodgkins or non-Hodgkins

Doctors trialing wireless enabled handheld devices to obtain immediate access to the latest patient information

ANSTO challenges doctors’ claims on reactor-produced nuclear medicines

Australian broadband for health suppliers chosen

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News